The Somatrem for Injection, cataloged under National Stock Number 6505-01-285-5743, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Eli Lilly and Company. Government technical data includes 6 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 4 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 11 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-285-5743 |
| Primary Part Number | 7335 |
| Item Name | Somatrem for Injection |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Eli Lilly and Company |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR |
| Physical Form | FREEZE-DRIED POWDER |
| Primary Container Type | VIAL |
| Total Primary Container Quantity | 6 |
| Features Provided | STERILE |
| Primary Container Content Quantity | 5.000 MILLILITERS AFTER RECONSTITUTION |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| 7335 PRIMARY | Eli Lilly and Company (USA) |
| NDC00002-7335-16 PRIMARY | Eli Lilly and Company (USA) |
| HUMATROPE INJECTION | Eli Lilly and Company (USA) |
| HUMATROPE | Eli Lilly and Company (USA) |
NSN 6505-01-285-5743 is a Somatrem for Injection, manufactured by Eli Lilly and Company, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-285-5743 has 4 cross-referenced part numbers: 7335 (Eli Lilly and Company), NDC00002-7335-16 (Eli Lilly and Company), HUMATROPE INJECTION (Eli Lilly and Company), HUMATROPE (Eli Lilly and Company).
There are 11 known substitutes for 6505-01-285-5743: 5365-00-202-8946, 1650-00-303-6631, 2930-00-354-3227 and 8 more. Verify interchangeability with system specifications before substitution.
Key specifications for 7335: Special Features: VIAL CONTAINS 5 MG SOMATROPIN,25 MG MANNITOL,5 MG GLYCINE,AND 1.13 DIBASIC SODIUM PHOSPHATE; PH APPROXIMATELY 7.5 WHEN RECONSTITUTED; EACH VIAL IS SUPPLIED IN COMBINATION WITH 5 ML VIAL OF DILUTING SOLUTION OF WATER FOR INJECTION AS A UNIT; 6 UNITS PER PACKAGE; Administration: INTRAMUSCULAR; Physical Form: FREEZE-DRIED POWDER; Primary Container Type: VIAL. 8 total characteristics are documented in the Federal Logistics Information System.